D
DIAMEDICA THERAPEUTICS INC
NASDAQ: DMAC (DiaMedica Therapeutics Inc.)
最近更新时间: 3小时之前4.06
0.01 (0.25%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | DiaMedica Therapeutics Inc. | 看涨 | 看涨 |
AIStockmoo 评分
1.1
| 分析师共识 | 3.5 |
| 内部交易活动 | NA |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.13 |
|
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 15.65% |
| 机构持股比例 | 34.27% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Omega Advisors Inc. | 31 Mar 2025 | 1,625,000 |
| First Manhattan Co. Llc. | 31 Mar 2025 | 606,435 |
| Paragon Associates & Paragon Associates Ii Joint Venture | 31 Mar 2025 | 600,000 |
| Bleichroeder Lp | 31 Mar 2025 | 382,317 |
| Lpl Financial Llc | 31 Mar 2025 | 155,300 |
| Royal Bank Of Canada | 31 Mar 2025 | 155,031 |
| 52周波幅 | ||
| 中 | 10.00 (146.31%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 19 Mar 2025 | 10.00 (146.31%) | 购买 | 5.24 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合